Statement from The Pew Charitable Trusts on the U.S. Food and Drug Administration's reversal on antibiotics safeguards in animal farming

Navigate to:

Statement from The Pew Charitable Trusts on the U.S. Food and Drug Administration's reversal on antibiotics safeguards in animal farming

WASHINGTON - Laura Rogers, project director for the Pew Campaign on Human Health and Industrial Farming, today issued the following statement regarding the U.S. Food and Drug Administration's decision to reverse its plan to ban off-label usage of certain antibiotics in animal agriculture:

"The misuse of antibiotics in animal agriculture helps fuel the increase in antibiotic-resistant infections – a fact long acknowledged by the American Medical Association, U.S. Centers for Disease Control and Prevention and even the FDA. Yet in another set-back for public health, the FDA reversed itself on the off-label use of cephalosporin – a family of antibiotics vitally important in human medicine – allowing this unrestricted use in industrial farm animal production to continue.

"Earlier this year, the agency had announced plans to ban all off-label uses in agriculture of these critical human drugs. Regrettably, the FDA changed its course.

"These important drugs are the only effective therapies for serious gastrointestinal diseases in children and also the best treatment for antibiotic-resistant infections in cancer patients. Easing restrictions on the use of cephalosporin on factory farms jeopardizes the effectiveness of these drugs and needlessly imperils our public health.

"In addition, the overuse of human antibiotics in farm animals is driving up the cost of healthcare. For example, in 1998 the Institute of Medicine estimated that antibiotic-resistant bacteria generated an estimated $4 billion to $5 billion per year in extra costs to the U.S. healthcare system.

"The incoming Administration and the new head of the FDA need to examine the overuse of antibiotics on factory farms. They must take the advice of the doctors and other public health professionals who have raised the alarm about antibiotic misuse and put the health of people – particularly susceptible groups like the elderly and children – ahead of industry profits. Change cannot come soon enough."

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.